150 related articles for article (PubMed ID: 32201193)
1. Synthesis, biological evaluation and virtual screening of some acridone derivatives as potential anticancer agents.
Oyedele AS; Bogan DN; Okoro CO
Bioorg Med Chem; 2020 May; 28(9):115426. PubMed ID: 32201193
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of novel acridone derivatives as antiproliferative agents.
Chen JN; Wu XK; Lu CH; Li X
Bioorg Med Chem; 2021 Jan; 29():115868. PubMed ID: 33191085
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Acridine/Acridone Analogs as Potential Anticancer Agents.
Gensicka-Kowalewska M; Cichorek M; Ronowska A; Deptuła M; Klejbor I; Dzierzbicka K
Med Chem; 2019; 15(7):729-737. PubMed ID: 30324889
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel amides based on acridone scaffold with interesting antineoplastic activity.
Mahajan AA; Rane RA; Amritkar AA; Naphade SS; Miniyar PB; Bangalore PK; Karpoormath R
Anticancer Agents Med Chem; 2015; 15(5):555-64. PubMed ID: 25469511
[TBL] [Abstract][Full Text] [Related]
5. Acridone-pyrimidine hybrids- design, synthesis, cytotoxicity studies in resistant and sensitive cancer cells and molecular docking studies.
Murahari M; Prakash KV; Peters GJ; Mayur YC
Eur J Med Chem; 2017 Oct; 139():961-981. PubMed ID: 28886509
[TBL] [Abstract][Full Text] [Related]
6. Structural optimizations and bioevaluation of N-substituted acridone derivatives as strong topoisomerase II inhibitors.
Li ZY; Xu GS; Song YL; Li X
Bioorg Chem; 2022 Feb; 119():105543. PubMed ID: 34929515
[TBL] [Abstract][Full Text] [Related]
7. Molecular design, synthesis and biological research of novel pyridyl acridones as potent DNA-binding and apoptosis-inducing agents.
Zhang B; Chen K; Wang N; Gao C; Sun Q; Li L; Chen Y; Tan C; Liu H; Jiang Y
Eur J Med Chem; 2015 Mar; 93():214-26. PubMed ID: 25686590
[TBL] [Abstract][Full Text] [Related]
8. Targeting tyrosine kinase: Development of acridone - pyrrole - oxindole hybrids against human breast cancer.
Kaur M; Singh P
Bioorg Med Chem Lett; 2019 Jan; 29(1):32-35. PubMed ID: 30446310
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, Biological Evaluation and Molecular Docking Study of Cyclic Diarylheptanoids as Potential Anticancer Therapeutics.
Lu Y; Yin W; Alam MS; Kadi AA; Jahng Y; Kwon Y; Rahman AFMM
Anticancer Agents Med Chem; 2020; 20(4):464-475. PubMed ID: 31763968
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, In Vitro Anti-cancer Activity, ADMET Profile and Molecular Docking of Novel Triazolo[3,4-a]phthalazine Derivatives Targeting VEGFR-2 Enzyme.
El-Helby AA; Sakr H; Ayyad RRA; El-Adl K; Ali MM; Khedr F
Anticancer Agents Med Chem; 2018; 18(8):1184-1196. PubMed ID: 29651967
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, antiproliferative activity and tubulin targeting effect of acridinone and dioxophenothiazine derivatives.
Verones V; Flouquet N; Lecoeur M; Lemoine A; Farce A; Baldeyrou B; Mahieu C; Wattez N; Lansiaux A; Goossens JF; Berthelot P; Lebegue N
Eur J Med Chem; 2013 Jan; 59():39-47. PubMed ID: 23202849
[TBL] [Abstract][Full Text] [Related]
12. Syntheses and evaluation of new acridone derivatives for selective binding of oncogene c-myc promoter i-motifs in gene transcriptional regulation.
Shu B; Cao J; Kuang G; Qiu J; Zhang M; Zhang Y; Wang M; Li X; Kang S; Ou TM; Tan JH; Huang ZS; Li D
Chem Commun (Camb); 2018 Feb; 54(16):2036-2039. PubMed ID: 29411851
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of novel cytotoxic tetracyclic acridone derivatives and study of their molecular docking, ADMET, QSAR, bioactivity and protein binding properties.
Veligeti R; Madhu RB; Anireddy J; Pasupuleti VR; Avula VKR; Ethiraj KS; Uppalanchi S; Kasturi S; Perumal Y; Anantaraju HS; Polkam N; Guda MR; Vallela S; Zyryanov GV
Sci Rep; 2020 Nov; 10(1):20720. PubMed ID: 33244007
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of quinazolinone tagged acridones as cytotoxic agents and their effects on EGFR tyrosine kinase.
Babu YR; Bhagavanraju M; Reddy GD; Peters GJ; Prasad VV
Arch Pharm (Weinheim); 2014 Sep; 347(9):624-34. PubMed ID: 24866341
[TBL] [Abstract][Full Text] [Related]
15. Syntheses and evaluation of acridone derivatives as anticancer agents targeting Kras promoter i-motif structure.
Wei Z; Lin X; Wang S; Zhang J; Ji D; Gong X; Huang ZS; Shu B; Li D
Bioorg Chem; 2023 Jul; 136():106526. PubMed ID: 37058782
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of acridone-2-carbohydrazide derivatives as p-AKT Ser
Yadav TT; Kumar MS; Bajaj S; Yc M
Future Med Chem; 2023 Apr; 15(8):699-716. PubMed ID: 37170843
[No Abstract] [Full Text] [Related]
17. Novel fluorinated acridone derivatives. Part 1: synthesis and evaluation as potential anticancer agents.
Fadeyi OO; Adamson ST; Myles EL; Okoro CO
Bioorg Med Chem Lett; 2008 Jul; 18(14):4172-6. PubMed ID: 18541426
[TBL] [Abstract][Full Text] [Related]
18. Design, green synthesis, molecular docking and anticancer evaluations of diazepam bearing sulfonamide moieties as VEGFR-2 inhibitors.
Saleh NM; El-Gaby MSA; El-Adl K; Abd El-Sattar NEA
Bioorg Chem; 2020 Nov; 104():104350. PubMed ID: 33142416
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antiproliferative activity of some novel benzo-fused imidazo[1,8]naphthyridinones.
Giannouli V; Kostakis IK; Pouli N; Marakos P; Samara P; Tsitsilonis O
Bioorg Med Chem Lett; 2015 Jul; 25(13):2621-3. PubMed ID: 25998504
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of N-(carbobenzyloxy)-l-phenylalanine and N-(carbobenzyloxy)-l-aspartic acid-β-benzyl ester derivatives as potent topoisomerase IIα inhibitors.
Han X; Zhong Y; Zhou G; Qi H; Li S; Ding Q; Liu Z; Song Y; Qiao X
Bioorg Med Chem; 2017 Jun; 25(12):3116-3126. PubMed ID: 28462840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
